Status:

NOT_YET_RECRUITING

Study on the Effect of Ultra-early Autologous Cranioplasty on Neurological Function Recovery

Lead Sponsor:

The Affiliated Hospital Of Guizhou Medical University

Conditions:

Cranial Defect

Eligibility:

All Genders

18-80 years

Phase:

NA

Brief Summary

To compare the neurological recovery and complication rate of autogenous cranioplasty(CP) within 6 weeks after decompressive craniectomy (DC) with that of autogenous cranioplasty within 3\~6 months af...

Detailed Description

Objective: To compare the neurological recovery and complication rate of autogenous cranioplasty(CP) within 6 weeks after decompressive craniectomy (DC) with that of autogenous cranioplasty within 3\...

Eligibility Criteria

Inclusion

  • Decompressive craniectomy due to craniocerebral trauma, cerebral ischemia and cerebral hemorrhage.
  • Age 18 - 80 years.
  • The first time for cranial repair.
  • unilateral skull defect.
  • Compliant with recommended decompressive bone flap surgery and autogenous decompressive bone flap after bone flap collection
  • signed the informed consent.

Exclusion

  • Poor healing of skin flap (active infection, non-healing, necrosis, sinus, thin or poor blood supply, etc.).
  • Fracture of bone flap ≥2 pieces, partial open fracture
  • Intracranial infection before operation.
  • Severe bone metabolic diseases.
  • Long-term use of immunosuppressants.
  • Pregnant or lactating women.
  • Coagulation disorders.
  • Severe cardiopulmonary insufficiency.
  • It is estimated that the CP process cannot be completed within 6 weeks after the bone plate decompression surgery.
  • Skull defect size less than 25cm².
  • Life expectancy less than 1 year.
  • mRS greater than 1 before primary disease.
  • Diabetic patients.
  • Patients who are unable to cooperate with follow-up assessment (e.g. mental illness).

Key Trial Info

Start Date :

October 1 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

September 1 2027

Estimated Enrollment :

582 Patients enrolled

Trial Details

Trial ID

NCT07183540

Start Date

October 1 2025

End Date

September 1 2027

Last Update

September 19 2025

Active Locations (7)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (7 locations)

1

Anshun People's Hospital (Ward One)

Anshun, Guizhou, China, 561000

2

Anshun People's Hospital (Ward Two)

Anshun, Guizhou, China, 561000

3

The First People's Hospital of Bijie City

Bijie, Guizhou, China

4

Guizhou Provincial Workers' Hospital

Guiyang, Guizhou, China